Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3356 |
|
Actual shortage: | 218 (6%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 10 (0%) | |
Resolved: | 3128 (93%) | |
Discontinuation Reports |
359 |
|
To be discontinued: | 24 (7%) | |
Discontinued: | 335 (93%) | |
Reversed: | 0 (0%) | |
Late reports |
144 (4%) |
|
Overdue reports |
62 (26%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-RANITIDINE TABLET 300MG | 300MG | TABLET | Resolved | 2017-06-08 | 2017-07-26 | 12364 |
APO-RANITIDINE TABLET 300MG | 300MG | TABLET | Resolved | 2017-08-30 | 2017-10-31 | 20645 |
APO-RANITIDINE TABLET 300MG | 300MG | TABLET | Resolved | 2017-05-04 | 2017-07-22 | 8889 |
APO-RANITIDINE TABLET 300MG | 300MG | TABLET | Actual shortage | 2019-09-18 | 2019-09-18 | 94177 |
APO-RASAGILINE | 1MG | TABLET | Resolved | 2020-06-24 | 2020-09-21 | 118775 |
APO-RASAGILINE | 0.5MG | TABLET | Resolved | 2017-06-27 | 2017-11-13 | 14011 |
APO-RASAGILINE | 1MG | TABLET | Resolved | 2023-03-16 | 2023-04-27 | 187244 |
APO-RASAGILINE | 1MG | TABLET | Resolved | 2023-11-17 | 2023-12-08 | 210743 |
APO-RASAGILINE | 1MG | TABLET | Resolved | 2019-02-24 | 2019-08-30 | 76743 |
APO-RASAGILINE | 0.5MG | TABLET | Resolved | 2019-06-12 | 2019-08-30 | 86327 |
APO-RASAGILINE | 0.5MG | TABLET | Resolved | 2021-12-17 | 2022-09-01 | 151360 |
APO-RASAGILINE | 1MG | TABLET | Resolved | 2021-12-17 | 2022-09-01 | 151367 |
APO-RASAGILINE | 0.5MG | TABLET | Resolved | 2017-03-11 | 2017-03-28 | 438 |
APO-RASAGILINE | 0.5MG | TABLET | Resolved | 2017-03-11 | 2017-03-28 | 441 |
APO-RASAGILINE | 0.5MG | TABLET | Resolved | 2017-03-11 | 2017-03-28 | 469 |
APO-RASAGILINE | 1MG | TABLET | Resolved | 2017-03-11 | 2017-03-28 | 472 |
APO-RASAGILINE | 1MG | TABLET | Resolved | 2017-05-04 | 2018-04-05 | 8892 |
APO-RASAGILINE | 1MG | TABLET | Resolved | 2020-10-21 | 2020-12-29 | 126777 |
APO-REPAGLINIDE | 0.5MG | TABLET | Resolved | 2017-03-11 | 2018-09-11 | 475 |
APO-REPAGLINIDE | 1.0MG | TABLET | Resolved | 2017-03-11 | 2018-09-11 | 478 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-VORICONAZOLE | 200MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60858 |
APO-VORICONAZOLE | 50MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60861 |
APO-ZOLMITRIPTAN | 2.5MG | TABLET | Discontinued | 2018-02-26 | 2018-02-26 | 40960 |
APO-ZOLMITRIPTAN | 2.5MG | TABLET | Discontinued | 2019-01-03 | 2019-01-03 | 71072 |
APO-ZOLMITRIPTAN RAPID | 2.5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2018-09-08 | 2018-09-15 | 60867 |
BISACODYL | 5MG | TABLET (DELAYED-RELEASE) | Discontinued | 2019-01-03 | 2019-01-03 | 71090 |
COATED DAILY LOW DOSE ASA 81 MG | 81MG | TABLET (DELAYED-RELEASE) | Discontinued | 2019-01-03 | 2019-01-04 | 71083 |
DOCUSATE SODIUM CAPSULES | 100MG | CAPSULE | Discontinued | 2018-02-23 | 2018-09-15 | 40738 |
IBUPROFEN | 200MG | TABLET | Discontinued | 2019-01-07 | 2019-01-07 | 71436 |
IBUPROFEN | 200MG | TABLET | Discontinued | 2019-01-07 | 2019-07-22 | 71439 |
IBUPROFEN CAPLETS | 200MG | TABLET | Discontinued | 2019-01-03 | 2019-01-03 | 71112 |
IBUPROFEN CAPLETS | 400MG | TABLET | Discontinued | 2019-01-07 | 2019-07-13 | 71451 |
IBUPROFEN CAPLETS | 200MG | TABLET | Discontinued | 2019-07-12 | 2019-07-13 | 89135 |
IBUPROFEN LIQUID GEL CAPSULES | 200MG | CAPSULE | Discontinued | 2019-01-03 | 2019-01-03 | 71095 |
MELPHALAN FOR INJECTION | 10ML 50MG | POWDER FOR SOLUTION KIT SOLUTION | Discontinued | 2022-03-23 | 2022-03-23 | 157136 |
NAPROXEN SODIUM TABLETS | 220MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71228 |
APO-TEMAZEPAM | 15MG | CAPSULE | Discontinued | 2018-10-23 | 2019-01-14 | 65477 |
APO-TEMAZEPAM | 30MG | CAPSULE | Discontinued | 2018-10-23 | 2019-01-07 | 65482 |
TIGECYCLINE | 50MG | POWDER FOR SOLUTION | To be discontinued | 2019-06-21 | 2019-06-21 | 87218 |